BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26005835)

  • 41. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.
    Roose JP; Mollenauer M; Ho M; Kurosaki T; Weiss A
    Mol Cell Biol; 2007 Apr; 27(7):2732-45. PubMed ID: 17283063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
    Peng Z; Raufman JP; Xie G
    PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
    Arany I; Faisal A; Nagamine Y; Safirstein RL
    J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RasGRP1, but not RasGRP3, is required for efficient thymic β-selection and ERK activation downstream of CXCR4.
    Golec DP; Dower NA; Stone JC; Baldwin TA
    PLoS One; 2013; 8(1):e53300. PubMed ID: 23308188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143.
    Akao Y; Kumazaki M; Shinohara H; Sugito N; Kuranaga Y; Tsujino T; Yoshikawa Y; Kitade Y
    Cancer Sci; 2018 May; 109(5):1455-1467. PubMed ID: 29498789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RasGRP1 is required for human NK cell function.
    Lee SH; Yun S; Lee J; Kim MJ; Piao ZH; Jeong M; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I
    J Immunol; 2009 Dec; 183(12):7931-8. PubMed ID: 19933860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.
    Dow LE; O'Rourke KP; Simon J; Tschaharganeh DF; van Es JH; Clevers H; Lowe SW
    Cell; 2015 Jun; 161(7):1539-1552. PubMed ID: 26091037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unique dependence on Sos1 in
    You X; Kong G; Ranheim EA; Yang D; Zhou Y; Zhang J
    Blood; 2018 Dec; 132(24):2575-2579. PubMed ID: 30377195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymic progenitors of TCRαβ
    Golec DP; Hoeppli RE; Henao Caviedes LM; McCann J; Levings MK; Baldwin TA
    J Exp Med; 2017 Aug; 214(8):2421-2435. PubMed ID: 28652304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
    Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APC loss-induced intestinal tumorigenesis in Drosophila: Roles of Ras in Wnt signaling activation and tumor progression.
    Wang C; Zhao R; Huang P; Yang F; Quan Z; Xu N; Xi R
    Dev Biol; 2013 Jun; 378(2):122-40. PubMed ID: 23570874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.
    Chen X; Priatel JJ; Chow MT; Teh HS
    J Immunol; 2008 May; 180(9):5973-82. PubMed ID: 18424717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of extracellular signal-regulated kinase but not of p38 mitogen-activated protein kinase pathways in lymphocytes requires allosteric activation of SOS.
    Jun JE; Yang M; Chen H; Chakraborty AK; Roose JP
    Mol Cell Biol; 2013 Jun; 33(12):2470-84. PubMed ID: 23589333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deoxycholic acid activates epidermal growth factor receptor and promotes intestinal carcinogenesis by ADAM17-dependent ligand release.
    Dong W; Liu L; Dou Y; Xu M; Liu T; Wang S; Zhang Y; Deng B; Wang B; Cao H
    J Cell Mol Med; 2018 Sep; 22(9):4263-4273. PubMed ID: 29956475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of Son of Sevenless Homologue 1 (SOS1): Promising therapeutic treatment for KRAS-mutant cancers.
    Chen T; Tang X; Wang Z; Feng F; Xu C; Zhao Q; Wu Y; Sun H; Chen Y
    Eur J Med Chem; 2023 Dec; 261():115828. PubMed ID: 37778239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colon epithelial cell differentiation is inhibited by constitutive c-myb expression or mutant APC plus activated RAS.
    Ramsay RG; Ciznadija D; Sicurella C; Reyes N; Mitchelhill K; Darcy PK; D'Abaco G; Mantamadiotis T
    DNA Cell Biol; 2005 Jan; 24(1):21-9. PubMed ID: 15684716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PAQR10 and PAQR11 mediate Ras signaling in the Golgi apparatus.
    Jin T; Ding Q; Huang H; Xu D; Jiang Y; Zhou B; Li Z; Jiang X; He J; Liu W; Zhang Y; Pan Y; Wang Z; Thomas WG; Chen Y
    Cell Res; 2012 Apr; 22(4):661-76. PubMed ID: 21968647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells.
    van Lidth de Jeude JF; Meijer BJ; Wielenga MCB; Spaan CN; Baan B; Rosekrans SL; Meisner S; Shen YH; Lee AS; Paton JC; Paton AW; Muncan V; van den Brink GR; Heijmans J
    Oncogene; 2017 Jun; 36(24):3397-3405. PubMed ID: 27819675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.